(1999). Antileukotriene agents in asthma: The dart that kills the elephant? CMAJ
(2002). ÇaIkog ˘lu I • ,A t Iș
Childhood asthma: Allergic disorders.
(1998). Disease Control (CDC). Forecasted statespecific estimates of self-reported asthma prevalence – United States,
(2000). Effectiveness and tolerability of zafirlukast for the treatment of asthma in children. Clin Ther
(2002). Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
(2004). Evaluation of montelukast in 8-14 year old children with mild persistent asthma and compared with inhaled corticosteroids. Allergol Immunopathol (Madr)
(2003). for the Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med
(2009). Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention,
(2009). Global Initiative For Asthma. A pocket guide for physicians and nurses ( Updated
(1998). Leukotriene modifiers in the treatment of asthma. BMJ
(2005). Long-acting bron -chodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma? Chest
(2006). Montelukast improves regional air trapping due to small airways obstruction in asthma.
(2006). Montelukast in pediatric asthma management.
(2003). Nitric oxide metabolites, eosinophils and eosinophilic cationic protein in patients with asthma: sputum versus blood.
(2005). Oral montelukast versus fluticasone propionate inhaler in persistent athma. Thesis submitted for fulfillment of master degree, Faculty of Medicine,
(2004). Pharmacokinetics of Montelukast in asthmatic patients 6 to 24 months old.
(2005). Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax
(2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet
(1991). Worldwide trends in asthma morbidity and mortality: Explanation of trends. Bull Int Union Tuberc Lung Dis
(1991). Worldwide trends in asthma mortality. Bull Int Union Tuberc Lung Dis
(2000). Zafirlukast and cromolyn are effective firstline therapies for child asthma. Ann Allergy Asthma Immunol